Singapore
Meridan ReportSingapore: APAC's finance and AI command center

Advertisement · Why this ad?

Technology

From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments

Katherine Langford
Editor-in-Chief · Friday, November 6, 2026 at 4:51 AM · 1 min read
From cancer to diabetes: Singapore biomedical startups expand into China to accelerate development of new treatments — Singapore Technology news

Singapore startups are tapping China’s vast patient pool, hospital networks and manufacturing capabilities, but they must also navigate its evolving regulatory landscape.

Up nextIREN tops quarterly revenue estimates, delays some Microsoft AI infrastructure deliveriesTechnology · 1 min read
#development#wellness
You're offline — showing the last loaded page